Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Hercules CEO snaps up shares

Fri 24 Jul 2026 14:28

(Sharecast News) - Hercules revealed on Friday that chief executive Brusk Korkmaz had acquired 100,000 ordinary shares in the AIM-listed infrastructure and construction services group. Korkmaz, who snapped up the shares in two separate transactions, purchased the shares at an average price of 39.75p each, for a total price of £39,750.

Following the transaction, Korkmaz holds a beneficial interest in 18.27m ordinary Hercules shares, representing approximately 23.68% of the company's issued share capital.

As of 1540 BST, Hercules shares were up 3.95% at 40.02p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Hercules (HERC) Director name: Korkmaz,Brusk Kivilcim Amount purchased: 70,000 @ 40.50p Value: £28,350.00

Henry Boot (BOOT) Director name: Sibley,Earl Amount purchased: 10,000 @ 154.00p Value: £15,400.00

Hercules (HERC) Director name: Korkmaz,Brusk Kivilcim Amount purchased: 30,000 @ 38.00p Value: £11,400.00

The Mission Group (TMG) Director name: Collins ,Claudine Amount purchased: 51,546 @ 19.39p Value: £9,994.77

Team (TEAM) Director name: Cusins,John Amount purchased: 32,258 @ 15.50p Value: £4,999.99

Top Director Sells

Share this article

Related Sharecast Articles

Thu 23 Jul 2026 15:27
Director dealings: Greencore chairman raises stake
(Sharecast News) - Greencore revealed on Thursday that non-executive chair Leslie Van de Walle had acquired 350,000 shares in the FTSE 250-listed food company.
Wed 22 Jul 2026 13:36
Director dealings: One Health Group director raises stake
(Sharecast News) - One Health Group revealed on Wednesday that non-executive director Zak McMurray had acquired 39,840 ordinary shares in the AIM-listed provider of NHS-funded surgical procedures.
Tue 21 Jul 2026 14:38
Director dealings: Supreme CEO snaps up shares
(Sharecast News) - Supreme revealed on Tuesday that chief executive officer Sandeep Chadha had acquired 500,000 prdonary shares in the AIM-listed consumer goods firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Policies and important information
 

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme

 

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026